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Background: Influenza is a significant cause of morbidity and mortality. The recent pandemic of a novel H1N1
influenza virus has stressed the importance of the search for effective treatments for this disease. Essential oils from
aromatic plants have been used for a wide variety of applications, such as personal hygiene, therapeutic massage
and even medical practice. In this paper, we investigate the potential role of an essential oil in antiviral activity.
Methods: We studied a commercial essential oil blend, On Guard™, and evaluated its ability in modulating
influenza virus, A/PR8/34 (PR8), infection in Madin-Darby canine kidney (MDCK) cells. Influenza virus was first
incubated with the essential oil and infectivity in MDCK cells was quantified by fluorescent focus assay (FFA). In
order to determine the mechanism of effects of essential oil in viral infection inhibition, we measured
hemagglutination (HA) activity, binding and internalization of untreated and oil-treated virus in MDCK cells by flow
cytometry and immunofluorescence microscopy. In addition, the effect of oil treatment on viral transcription and
translation were assayed by relative end-point RT-PCR and western blot analysis.
Results: Influenza virus infectivity was suppressed by essential oil treatment in a dose-dependent manner; the
number of nascent viral particles released from MDCK cells was reduced by 90% and by 40% when virus was
treated with 1:4,000 and 1:6,000 dilutions of the oil, respectively. Oil treatment of the virus also decreased direct
infection of the cells as the number of infected MDCK cells decreased by 90% and 45% when virus was treated
with 1:2,000 and 1:3,000 dilutions of the oil, respectively. This was not due to a decrease in HA activity, as HA was
preserved despite oil treatment. In addition, oil treatment did not affect virus binding or internalization in MDCK
cells. These effects did not appear to be due to cytotoxicity of the oil as MDCK cell viability was only seen with
concentrations of oil that were 2 to 6 times greater than the doses that inhibited viral infectivity. RT-PCR and
western blotting demonstrated that oil treatment of the virus inhibited viral NP and NS1 protein, but not mRNA
expression.
Conclusions: An essential oil blend significantly attenuates influenza virus PR8 infectivity in vitro without affecting
viral binding or cellular internalization in MDCK cells. Oil treated virus continued to express viral mRNAs but had
minimal expression of viral proteins, suggesting that the antiviral effect may be due to inhibition of viral protein
translation.
Background
The recent pandemic of a novel H1N1 influenza empha-
sizes the urgency of identifying effective approaches to
prevent viral infection. Between 1990 and 1999 in the
United States, non-pandemic influenza A virus (IAV)
infected 5-20% of people and caused approximately
36,000 deaths and 226,000 hospitalizations annually [1,2].
IAV infection is initiated with a binding of the viral
hemagglutinin (HA) to sialic acid on the cell surface; and
virus particles are internalized through receptor-
mediated endocytosis. While in the endosome, viral HA
protein is activated and the virus fuses with endosomal
membranes. After fusion, IAV shuts off host cell protein
synthesis and cell replication. As a result, infected cells
die by apoptosis or cytolysis.
Essential oils have been used for aromatherapy, mas-
sage therapy, emotional health, personal care, nutritional
supplements, or cleaning for many years. The modern
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any medium, provided the original work is properly cited.use of essential oils has grown rapidly as health scien-
tists and medical practitioners have found scientific evi-
dence for the benefits of this therapy. In Japan, Perillae
H e r b a( al e a fo fPerilla frutescens) has been prescribed
to treat depression. It has been shown that l-Perillalde-
hyde, a major component in the essential oil containing
in Perillae Herba, is responsible for the antidepressant-
like activity through stimulation of the olfactory nerve
[3]. Essential oil from Boswellia carteri and Boswellia
serrata have been used for the treatment of rheumatoid
arthritis and other inflammatory diseases in traditional
medicine for many years [4,5]. Studies showed that fran-
kincense oil derived from Boswellia species possess
anti-inflammatory activity though inhibition of immune
cytokines production and leukocyte infiltration [6-8]. In
addition, many other essential oils used in aromatherapy
have medicinal properties including antiseptic properties
[9], and mood enhancing effects [10,11].
Distinctive chemical components of plants protect
them from insects, bacteria or viruses that cause dis-
eases. Essential oils prepared from plants, therefore,
might be effective in protecting humans from viral
infection. In addition to their intrinsic benefits to plants
and as fragrances for people, essential oils have been
used throughout history in many cultures for their med-
icinal and therapeutic benefits. They were first used in
ancient Egypt for treatment of various illnesses and
other physical and spiritual needs. Borrowing from the
Egyptians, the Greeks, Romans, Indians, Persians, as
well as Chinese began to refine distillation methods for
extracting oils from aromatic plants and have used them
extensively in medical practice for diverse purposes,
such as promoting wellness, enhancing personal hygiene,
and in therapeutic massage and aromatherapy. They
have also been used as a beauty treatment, in food pre-
paration, and in religious ceremonies.
In this study, we evaluated the effect of a commer-
cially available essential oil blend, On Guard™, on influ-
enza virus A/PR/8/34 (PR8) infection in Madin-Darby
canine kidney (MDCK) cells. This oil blend combines a
mixture of wild orange, clove, cinnamon, eucalyptus and
rosemary. The mechanism of the oil-mediated inhibition
of viral infectivity was also investigated.
Methods
Reagents and chemicals
Cell culture medium MEM and DMEM/F12 (1:1), fetal
calf serum (FCS), and penicillin-streptomycin were pur-
chased from Invitrogen (Carlsbad, CA). Trypan blue was
purchased from Sigma (St. Louis, MO). On Guard™ pro-
tective blend oil was obtained from dōTERRA Interna-
tional (Orem, UT). Mouse anti-IAV nucleoprotein (NP)
monoclonal antibody was purchased from Abcam
( C a m b r i d g e ,M A ) .A l e x aF l u r o4 8 8 - c o n j u g a t e dg o a t
anti-mouse IgG was purchased from Molecular Probes
(Eugene, OR). Goat anti-IAV NS1 polyclonal antibody
was purchased from Santa Cruz (Santa Cruz, CA).
Preparation of influenza virus stock and cell culture
Influenza A/PR/8/34 (PR8), a laboratory adapted H1N1
IAV strain, was passaged in MDCK cells. MDCK cells
were cultured in DMEM supplemented with 10% FCS.
Viruses were grown in MDCK cells in DMEM/F12 with
ITS+ (containing insulin, human transferrin, and sele-
nous acid; BD Biosciences, Franklin Lakes, NJ) and tryp-
sin (0.5 μg/ml), harvested at 72 h postinfection and
titered by plaque assay in MDCK cells. There was no
detectable endotoxin in the final viral preparations used
in the experiments as determined by limulus amebocyte
lysate assay (Cambrex, Walkersville, MD). The assay has
a detection limit of 0.1 EU/ml or approximately 20 pg/
ml lipopolysaccharide (LPS).
For essential oil-treated influenza virus, PR8 virus was
mixed with serial dilutions of the essential oil and incu-
bated at room temperature for 2 h. PR8 virus mixed
and incubated in 1-1,000 dilutions of canola oil was
used as a control. Oil-treated and untreated IAV was
stored at -80°C until use.
Fluorescent focus assay (FFA)
To determine the release of IAV infectious particles
from oil-treated and untreated IAV-infected MDCK
cells, cells were grown to confluence in 24-well plates
a n do i l - t r e a t e da n du n t r e a t e dP R 8v i r u sw a sa d d e da t
the multiplicity of infection (MOI) of 1 and incubated at
37°C in a cell incubator. At 48 h after infection, 50 μl
aliquots of cell culture supernatants were collected and
transferred to 96-well plates containing confluent
MDCK cells. The supernatants were serially diluted with
PBS containing 0.6 mM CaCl2 and 0.5 mM MgCl2
(CaMg-PBS) and incubated with the MDCK cells for 45
minutes at 37°C, followed by washing of the cells three
times in serum-free DMEM/F12 with ITS+ containing
1% penicillin and streptomycin. The cells were main-
tained in DMEM/F12 with ITS+.
After 6 h at 37°C, the MDCK monolayers were subse-
quently washed three times with PBS and fixed with 4%
paraformaldehyde for 10 min at 4°C followed by per-
meabilization with 2% Triton X-100 for 10 min in room
temperature. The cell monolayers were then labeled by
incubating with a monoclonal antibody (Abcam, Cam-
bridge, MA) against the IAV NP in Staining Buffer (PBS
with 0.1%BSA, 1% heat-inactivated human serum, 0.02%
NaN3) for 30 min at 4°C. Following washes with PBS,
Alexa Fluor 488-conjugated goat anti-mouse IgG was
added to detect antibody binding to the IAV NPs. Initi-
ally, various dilutions of virus were used to find the
dose yielding ~50 fluorescent foci per high powered
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cells in general.
Cell viability analysis
To determine the MDCK cell viability following essen-
tial oil treatment, cells were seeded in 24-well tissue cul-
ture plates at the density of 5 × 10
4 cells/well in 500 μl
growth medium for adherence. Aliquots of 500 μl vary-
ing dilutions from 1:3,000 to 1:18,000 (v/v) of the oil
blend in cell growth media were added to each well in
triplicate. Cell viability was determined at 7 h and 24 h
following protective blend oil exposure using a Trypan
blue (0.4% w/v) exclusion assay. Cell viability was
counted using a hemocytometer, and expressed as the
percentage of trypan blue positive cells over the total
number (stained + unstained) of cells.
Hemagglutinin titration of influenza virus
For HA assay, viruses were serially 2-fold diluted in a
96-well plate with CaMg-PBS and an equal volume of
0.5% human red blood cells were added. The plates
were kept at 4°C for 60 minutes and agglutination was
determined visually.
Flow cytometry analysis and confocal microscopy of IAV
binding and internalization
To prepare the cells for flow cytometry and confocal
microscopy to examine viral binding and internalization,
MDCK cells in exponential growth phase were trypsi-
nized and resuspended in DMEM. Cells (5 × 10
5) in 100
μl were exposed to PR8 at an MOI of 50, and incubated
at 4°C for 30 minutes to allow virus binding. A negative
control was performed by exposing cells to an equal
volume of sterile virus-free buffer. For oil-treated virus,
PR8 was incubated in the protective essential oil at a
dilution of 1 to 4,000 for 2 h prior to the exposure. For
virus internalization, cells were further incubated with
virus at 37°C for 30 minutes. Surface associated virus
was removed by incubating the cells in sialidase from
Clostridium perfringens (Sigma, St Louis, MO) at 40 mU
in 200 μlo fC M S / A c ,p H5 . 5( 1 5 0m MN a C l ,1 0m M
CaCl2 and 0.5 mM MaCl2)f o r1ha t3 7 ° Cw i t hg e n t l e
rocking. Following the incubation with virus and/or sia-
lidase, the cells were washed in triplicate to remove
unbound virus and then incubated for 20 minutes in
100 μl stain buffer (BD Biosciences, San Jose, CA) with
5% FCS containing 1 μl canine IgG solution as an FcR
blocker. After being treated with Perm/Wash Buffer (BD
Biosciences) for 10 minutes, the cells were stained with
an anti-IAV NP monoclonal antibody followed by
incubation with an Alexa Fluor 488-conjugated goat
anti-mouse IgG for 40 minutes. The cells were fixed by
incubating on ice with 250 μl Cytofix (BD Biosciences)
and then washed in triplicate. For FACS analysis, the
cells were resuspended in 250 μl Stain Buffer; and single
cell suspensions were prepared using a mesh filter. A
FACScan cytometer, BD Biosciences LSR II, was used to
assess PR8 binding and internalization. A minimum of
twenty thousand events were counted for each sample.
Analytical gates were set so that ≤1% of negative control
cells exceeded the gate. The percentage of cells exceed-
ing the gate was used to determine virus binding and
internalization. For confocal microscopy, the cells were
resuspended in 200 μl of Stain Buffer and mounted on
microscope slides using acrylic-based mounting medium
containing DAPI (Invitrogen).
Measurement of viral mRNA expression by relative end-
point RT-PCR
MDCK cells were exposed to oil-treated or untreated
PR8 at an MOI of 32. For mock infection, cells were
exposed to sterile virus-free buffer. After 18 h, total
RNA from MDCK cells was extracted using TRIzol
(Invitrogen, Carlsbad, CA). The quantity and quality of
the isolated RNA was determined spectrophometrically
and by formaldehyde agarose gel electrophoresis, respec-
tively. An equal amount (1 μg) of the total RNA was
reverse transcribed for first-strand cDNA synthesis.
Then an aliquot of the cDNA was subjected to 30 cycles
of PCR amplification (95°C, 30 sec.; 55°C, 1 min.; 72°C,
1 min.) in the presence of primer pairs targeting NP,
NS1 or GAPDH. The following primer sequences were
used: NP sense 5’-AGGACAAGAGCTCTTGTTCG-3’,
and anti-sense 5’-CTCTTGTGTGCTGGATTCTC-3’;




CAC-3’. Aliquots of 25 μl PCR products were electro-
phoresed on 1% agarose gels and visualized by ethidium
bromide staining. DNA bands were imaged and quanti-
fied using ImageQuant 5.0 software (GE Healthcare,
Piscataway, NJ). Levels of NP and NS1 were normalized
to the corresponding GAPDH levels for each sample.
Viral NS1 protein determination by immunoblotting
MDCK cells were exposed to oil-treated or untreated
PR8 at an MOI of 32. For mock infection, cells were
exposed to an equal volume of virus-free buffer. Cells
were harvested at 18 h following infection by lysing the
cells with RIPA buffer (150 mM NaCl; 50 mM Tris, pH
8.0; 10 mM EDTA, NaF, and sodium pyrophosphate; 1%
NP-40; 0.5% sodium deoxycholate; 0.1% SDS; 10 μgo f
leupeptin/ml). Cell homogenates were clarified by cen-
trifugation at 4°C; and 20 to 30 μgo ft h el y s a t e sw e r e
separated on 4-15% gradient SDS-PAGE gels. Proteins
were then transferred onto nitrocellulose membranes.
Following blocking with 3% non fat milk plus 1% BSA,
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b-actin (Abcam) antibody overnight followed by incuba-
tion with horseradish peroxidase-conjugated rabbit
anti-goat IgG (Cell Signaling Technology). Target pro-
tein binding was detected using a chemilluminescent
reagent (Pierce Biotechnology, Rockford, IL), and visua-
lized by the Syngene G:box Bioimaging System and
GeneTools software (Syngene, Frederick, MD).
Statistical analysis
Results are reported as the mean ± standard error of
mean (SEM) of at least three replicate experiments. All
statistical analysis was carried out with GraphPad Instat 3.
Statistical significance was determined by one-way
ANOVA with Student-Newman-Keuls post hoc correction
for multiple comparisons. Statistical significant was
considered when p < 0.05.
Results
Protective essential oil suppressed progeny virus
production
The effect of oil treatment on viral infectivity was first
determined by measuring the release of nascent viral par-
ticles following infection of MDCK cells with untreated,
oil treated, or control oil treated virus for 48 h.
Quantification of infectious particles produced in
virus-exposed MDCK supernatant was done by transfer
of the infected cell supernatant to a separate culture of
MDCK cells followed by Fluorescent focus assay (FFA).
The fluorescent foci were counted by fluorescent
microscopy. There was no detectable green fluorescent
signal in cells exposed to virus-free diluents (Figure
1A, top panels). Oil treatment inhibited nascent PR8
production and release into infected supernatants in a
dose dependent manner (Figure 1). Virus treatment
with control canola oil (1:1,000) had no significant
effect on viral particle production (Figure 1G and 1H,
top panels). IAV pretreatment with protective oil
decreased production of viral particles (Figure 1B-F,
top panels).
Virus treated with a 1:4,000 dilution of protective
essential oil decreased the infectious particle number by
90% (Figure 1, bottom panel). This did not appear to be
due to a toxic effect of the oil on MDCK cells. Because
addition of treated virus to MDCK cells resulted in a
further dilution of the oil in the media, cells were actu-
ally exposed to protective oil at a concentration 1,500
times lower than that used to treat the virus. For exam-
ple, treatment of the virus with a 1 to 3,000 dilution of
oil resulted in exposure of the MDCK cells to a cellular
exposure to a 1 to 4,500,000 dilution of oil. This is far
below the minimal concentration that caused any
detectable cellular cytotoxicity (1: 3,000; Figure 5). Thus,
it appeared that the protective oil inhibited IAV PR8
viral production in MDCK cells was not due to non-
specific cytotoxicity.
Protective essential oil suppresses virus infection
To determine whether protective oil directly inhibited
the first cycle of IAV infection, oil-treated PR8 was
added to MDCK cells and direct FFA assay of the
infected cells was performed. Fluorescent foci of infected
cells were easily detectable after 7 h of exposure to
untreated or control canola oil (1:1,000) treated PR8.
The nascent produced nucleoprotein (NP) by FFA was
significantly decreased by virus treatment by oil at con-
centrations greater than 1 to 3,000 (Figure 2B-D, top
panels). Treatment of PR8 with a 1 to 3,000 dilution of
oil decreased the number of infected MDCK cells by
50% (Figure 2, bottom panel). As the oil was further
diluted, the final oil dilutions applied to MDCK cells
during exposure to virus were 3 fold higher (more
dilute) than those used to treat virus in this experiment.
For example, treatment of virus with a 1 to 3,000 dilu-
tion of oil resulted in MDCK cell exposure of 1 to
9,000. Thus, the protective essential oil significantly
inhibited IAV PR8 viral protein production in MDCK
cells at concentrations that did not appear to be directly
toxic to cells.
Effect of oil treatment on HA activity
To determine whether the effect of protective oil on
virus infectivity was due to alterations in virus particle
integrity, the effect of oil treatment on HA activity was
assessed. HA activity was measured in untreated PR8
virus or virus treated with various dilutions of protective
oil or control oil for 24 h, 48 h and 72 h. Although HA
activity decreased with time for all treated and mock
treated viruses, there was no significant effect of oil
treatment on HA activity (Table 1) at several concentra-
tions that decrease viral infectivity and progeny virus
production. There was a modest effect of a 1 to 1,000
dilution on HA activity after 72 h oil treatment. This
effect was not seen when dilutions greater than 1:1,000
were used, even with 72 h of exposure. This data shows
that the effect of oil treatment on infectivity and viral
progeny production was not due to inhibition of HA
activity.
Binding and internalization of virus in MDCK cells
In order to examine the mechanism of inhibition of PR8
by oil treatment, the effect of this treatment on virus
internalization was studied. To this end, we developed a
flow cytometry (FACS) internalization assay. Virus was
detected using an Alexa Fluor 488 labeled secondary
antibody against monoclonal antibody to PR8 NP. At 4°C,
virions attach to the host cell surface, but internalization
does not occur. Sialidase is then used to remove the
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Page 4 of 13Figure 1 Effect of oil treatment on progeny virus production by PR8 as measured by Fluorescent focus assay (FFA). After MDCK cells in
24-well plates were infected with oil-treated and untreated virus for 48 h, five microliters of supernatants were removed, serially diluted and
added to confluent MDCK cells in 96-well plates. After incubation for 7 h, IAV nucleoprotein (NP) was detected using an Alexa Fluor 488 (green)
labeled antibody. Panels: (A) MDCK cells unexposed to virus, but stained with anti-NP antibody. Panels (B-F) MDCK cells exposed to PR8 treated
with different dilutions of essential oil: (B) 1:1,000 (C) 1:2,000 (D) 1:3,000 (E) 1:4,000 (F) 1:6,000, (G) untreated PR8, (H) PR8 treated with control oil
at a 1:1,000 dilution. Panels I-L were fluorescence images merged with corresponding brightfield images to show MDCK cell morphology: (I) PR8
treated with essential oil 1:4,000, (J) PR8 treated with essential oil 1:6,000, (K) untreated PR8, (L) PR8 treated with control oil 1:1,000 (merge).
Bottom panel: Infectivity as reflected by the percentage of cells in which IAV NP was detected. The results represent the mean ± SEM from three
independent experiments.
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Page 5 of 13Figure 2 Effect of essential oil on the first cycle of PR8 infection as determined by FFA. MDCK cells in 96-well plates were infected by oil-
treated virus for 7 h, and viral NP was detected using an Alexa Fluor 488 (green) labeled antibody. Panels: (A) MDCK cells unexposed to virus,
but stained with anti-NP antibody. Panels B-F cells exposed to PR8 treated with dilutions of essential oil (B) 1:1,000 (C) 1:2,000 (D) 1:3,000 (E)
1:4,000 (F) 1:5,000, (G) 1:6,000, (H) untreated PR8, (I) PR8 treated with control oil 1:1,000. Panels I-L were fluorescence images merged with
corresponding brightfield images to show MDCK cell morphology (J) PR8 treated with essential oil 1:1,000, (K) PR8 treated with essential oil
1:6,000, (L) untreated PR8 (merge). Bottom panel: PR8 first cycle NP production as depicted by the percentage of cells containing detectable NP
at 7 h after infection. The results represent the mean ± SEM from three independent experiments.
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present after sialidase treatment is presumed to be inter-
nalized, and this was indeed confirmed by confocal micro-
scopy (see below). FACS assay demonstrated as expected
that PR8 bound to receptors at the cell surface but was
not internalized at 4°C as the cell-associated fluorescence
of stained influenza virus was removed by sialidase (Figure
3, left panels). At 37°C, PR8 internalization occurred, as
cell-associated fluorescence was not removed by sialidase
treatment (Figure 3, left panels). As determined by the
FACS assay, oil treatment did not affect virus binding to
MDCK cells. Also, internalization was not detectably
affected by oil treatment of PR8 as determined by the
amount of sialidase-resistant cell associated fluorescence
after incubation of virus exposed cells at 37°C (Figure 3E,
L, right panels).
Results from confocal microscopy confirmed the
results of the flow cytometry assay for virus binding and
internalization (Figure 4). At 4°C, viruses remained on
the cell surface as shown as a green fluorescent ring
around the cell membrane (Figure 4, panel A and F). In
contrast, the viruses were present in the cytoplasm
after incubation at 37°C (Figure 4, panel C and H). Cell-
associated influenza virus in cells incubated at 4°C was
removed by sialidase, but not after incubation at 37°C
confirming that sialidase treatment removed the surface
bound, but not internalized, virus (Figure 4, panel B, G,
D and I). There was no apparent effect of oil treatment
on binding and internalization of PR8. Together, these
data demonstrate that oil treatment does not appear to
inhibit IAV infectivity and progeny production by altera-
tion of virus binding and internalization.
Effect of essential oil on cell viability
To determine if essential oil inhibited virus infectivity
and progeny production by direct cellular cytotoxic
effects, the viability of MDCK cells was measured after
incubation with media in the presence or absence of oil.
Viability was determined by morphological examination
and trypan blue exclusion. Dilutions of oil correspond-
ing to final concentrations of the cells were also used.
This was to account for the fact that after oil exposure
of the virus, addition of treated virus to MDCK cells
resulted in a further dilution of the oil in the media.
Therefore, dilutions of protective oil (1:3,000 to
1:18,000) in cell growth media, corresponding to work-
ing dilutions for cells in FFA assay, were added to each
well in triplicate. For these experiments, two incubation
times were used. Seven-hour incubation was used to
duplicate the exposure of MDCK cells to oil during the
assay for the effect of oil on the first cycle of virus infec-
tion (see Figure 2). Twenty-four hours of exposure were
used to duplicate the oil exposure during the assay for
the effect of oil treatment on viral progeny production
(see Figure 1).
Morphologically, oil-treated cells did not show signs of
death at 7 h. At 24 h of exposure, MDCK cells remained
attached to the bottom of plates and did not show
noticeable morphological alterations at the dilution up
to 1:3,000.
Cell viability by trypan blue exclusion was also deter-
mined at 7 and 24 h following exposure to the essential
oil blend. At all concentrations of oil, all MDCK cells
were alive after 7 h of incubation. After 24 h, cell viabi-
lity was not significantly affected by the increasing con-
centrations of protective blend oil up to a 1: 3,000
dilution (Figure 5). At this concentration about 60% of
the cells were dead. Control oil (canola oil, 1:1,000) did
not cause any cell death after 24 h. As there was no
effect of any concentration the oil on cell viability at 7 h
the effect of oil treatment on the first cycle of viral
infection does not appear to be due to cytotoxicity.
Also, as the oil concentrations causing cytoxicity after
24 h of incubation were much greater than those that
inhibited viral progeny production, it appears that this
effect of oil treatment is not due to cytotoxic effects of
the oil.
MDCK cells infected by oil-treated virus express viral
mRNA, but minimal amounts of protein
We next sought to determine whether the effects of oil
treatment on viral infectivity and progeny production
could be due to inhibition of viral gene expression at
the transcriptional level. Endogenous mRNA levels of
viral NP were determined using relative end-point RT-
PCR. As expected, when cells were exposed to virus at
4°C, no viral NP RNA was detected, consistent with
virus binding, but failing to internalize under these con-
ditions. At 37°C, RNA expression of NP was detected in
cells infected with both oil-treated virus and untreated
Table 1 HA titration comparison of essential oil-treated to untreated influenza virus*
Essential Oil Dilution
Time (h) after oil treatment No Oil 1/1000 1/2000 1/3000 1/4000 1/5000 1/6000 Control Oil
2 4 5555555 5
4 8 4444444 4
7 2 3233333 3
*HA titer showing by the last well forming hemagglutination.
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Page 7 of 13Figure 3 Essential oil dose not block IAV PR8 binding and entry to MDCK cells as determined by flow cytometry.M D C Kc e l l sw e r e
exposed to oil-treated (1:4,000 dilution) and untreated PR8. Viruses were allowed to bind to the cells at 4°C for 30 minutes, or allowed to bind
and then internalize at 37°C for 30 minutes. Following the incubation of selected samples with sialidase treatment, viral NP was stained with the
fluorescent dye Alexa Fluor 488. The percentage of cells exceeding the analytical gate was used to determine viral binding and internalization.
The data are representative of three separate experiments.
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Page 8 of 13PR8 virus. NP mRNA expression levels were similar
whether oil-treated or untreated virus was used (Figure 6).
This finding suggests that the decrease in NP protein
expression seen with oil treatment (see Figure 2) was likely
due to inhibition of viral mRNA transcription.
To confirm whether oil treatment inhibited viral pro-
tein but not mRNA production, we also measured
mRNA and protein expression levels of another viral
protein, NS1, in control and oil treated virus-exposed
cells. As with viral NP, mRNA expression of NS1 was
not affected by oil treatment of PR8 (Figure 7A). In con-
trast, NS1 protein expression was significantly decreased
by treatment of PR8 with essential oil. (Figure 7B).
Based on the above results, inhibition of viral progeny
production and infection by essential oil is likely due to
inhibition of viral protein synthesis.
Figure 4 Essential oil dose not block IAV PR8 binding and ent r yi nM D C Kc e l l sa sc o n f i r m e db yc o n f o c a li m a g i n g .B i n d i n ga n d
internalization of oil treated (1:4,000 dilution) and untreated PR8 virus to MDCK cells was examined as described in Figure 3. Following infection,
NP was stained with the fluorescent dye Alexa Fluor 488. Cell nuclei were stained with DAPI (purple).
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Page 9 of 13Figure 5 Effects of essential oil treatment on PR8 production are not due to cytotoxicity. Cell viability was determined using trypan blue
exclusion at 7 and 24 h of essential oil exposure. Data were presented as the mean ± SEM from at least 3 independent experiments. Means
were compared to data from the control oil group. **P < 0.01.
Figure 6 Essential oil treatment does not inhibit PR8 NP mRNA expression in MDCK cells. After infection of MDCK cells with oil-treated
(1:4,000 dilution) and untreated PR8 virus at 4°C or 37°C for 18 h, total RNA was extracted and PR8 NP mRNA expression was assessed by
relative end-point RT-PCR (A). Transcript levels of NP normalized relative to the constitutively expressed GAPDH gene (B). The data are
representative of three separate experiments.
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In order to develop novel therapies, many plant extracts
have been tested for antiviral activity. Over the last dec-
ade, laboratory research has found that many essential
oils diminish viral infectivity. For example, Melissa offici-
nalis oil decreases infectivity of enveloped herpesviruses
[12]. Essential oils from hyssop, thyme or ginger
have inhibitory effects on herpes simplex virus type 2
(HSV-2) in vitro as determined by plaque assay in
RC-37 cells [13].
With regard to IAV, Melaleuca alternifolia essential
oil has antiviral activity against influenza PR8 virus and
that antiviral activity has been principally attributed to a
specific component, terpinen-4-ol [14]. The anti-IAV
activity is manifested by inhibition of virus-induced
cytopathogenicity. Also, a polyphenol rich extract
( C Y S T U S 0 5 2 )f r o mt h eM e d i t e r r a n e a np l a n tCistus
incanus exerts potent anti-influenza virus activity in
A549 or MDCK cell cultures infected with IAV. On a
molecular basis the protective effect of CYSTUS052
appears to be mainly due to binding of the polymeric
polyphenol components of the extract to the virus sur-
face, thereby inhibiting binding of the hemagglutinin to
cellular receptors [15]. Echinacea purpurea extract has
activity against highly pathogenic avian influenza virus,
via inhibition of cell receptor binding activity of the
virus [16].
Replication of the virus RNA genome in infected cells
was found to be constantly suppressed in the presence of
the Agrimonia pilosa extract. The data suggests that the
extract exerts an antiviral effect on multiple rounds of
the influenza infection cycle, primarily the initial step of
the virus life cycle, but activity at later stages, including
replication and transcription, cannot be ruled out [17].
Figure 7 MDCK cells infected by oil-treated virus express viral NS1 mRNA, but minimal amounts of NS1 protein. After infection of MDCK
cells with oil-treated (1:4,000 dilution) and untreated PR8 virus at 4°C and 37°C for 18 h. Total RNA was extracted from cells and PR8 NS1 mRNA
expression was assessed by relative end-point RT-PCR (A). Transcript levels of NS1 normalized relative to the constitutively expressed GAPDH
gene (B). Western blot was used to determine NS1 protein expression in the infected cells (C). The membranes were probed with anti-NS1 or
anti-actin antibodies. The data depicted are representative of three separate experiments.
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Page 11 of 13Study of catechins in green tea on influenza virus sug-
gests that the antiviral effect of catechins on influenza
virus is mediated not only by specific interaction with
HA, but altering the physical properties of viral mem-
brane [18]. Here, we report that a blend of essential oil
attenuates IAV infection in MDCK cells. Our work
shows that the mechanism of antiviral activity is due to
inhibition of viral protein synthesis. This mechanism of
inhibition is similar to that of trans-cinnamaldehyde
(CA), one of the principal constituents of essential oil
derived from Cinnamomi cortex. This extract inhibits the
growth of influenza PR8 virus in vitro and inhibited viral
protein, but not mRNA synthesis [19]. In this study, they
were also able to demonstrate a protective effect of CA in
PR8 infected mice. Thus, the inhibitory activity of plant
extracts appears to be at multiple stages of viral infection
and proliferation.
Some traditional herbal medicines have been used for
the treatment of various diseases for more than 2,000
years. Recently some have been officially approved for
clinical use. For example, aspirin was originally made
from powder of the bark and leaves of the willow tree
to help heal headaches, pains and fevers back in Hippo-
crates days. Currently, 148 Japanese kampo medicines
have now formally been approved by the Ministry of
Health, Labor and Welfare of Japan for use in clinics. In
addition, several kampo were shown to have immuno-
modulatory and anti-viral effects both in vitro and
in vivo [20]. With more understanding of their antiviral
mechanisms, more traditional medicines will be utilized
for clinical pharmaceutical purposes and novel drug
discovery.
The lack of toxicity and potent specific viral inhibitory
activity suggest essential oil may be helpful as a possible
antiviral drug for control and treatment of influenza
virus infection. It could potentially be used as a non-
toxic way to cleanse surfaces, or dispersed to eliminate
aerosolized virus particles in confined areas. Since the
oil is currently used as a food supplement, oral adminis-
tration, once the pharmacokinetics are determined, may
provide therapeutic benefit during infection.
Conclusions
We have shown that virus treated with protective essen-
tial oil significantly decreased both the number of
released viral particles from infected MDCK cells, and
infected cells by FFA assay. Also, oil treated virus had
the same ability to bind to and internalize in MDCK
cells compared with untreated virus. MDCK cells
infected by oil-treated virus express viral mRNA, but
minimal amounts of protein. Taken together, we found
an essential oil blend notably attenuates influenza virus
PR8 infection in vitro via inhibition of viral protein
synthesis at the post-transcription level. The lack of
toxicity and potent specific inhibition ability make the
essential oil a possible antiviral drug for influenza virus
proliferation control and treatment.
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